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Staph Bacteria from First Breath
The Interweaving of the Nasal Microbiome with the Intricate and Complex Nose
by Dr. Alan L. Gillen on January 25, 2017
Abstract
Many microbes live in a mutualistic relationship with the human body, make up the human microbiome,
and play a role in our health by stimulating and modulating the immune system. Man’s body is “covered”
both inside and outside with millions of microbes that play a role in maintaining normal bodily functions
and sustaining life in our changing world. The inner nose in the human body is colonized by millions of
microbes during the ﬁrst week of life. This internal colonization of the upper respiratory system is termed
our nasal microbiome. Though we cannot see it, this microbiome is important for normal functioning,
especially in a pathogenic world.
Staphylococci interact to stimulate the immune system, and play a role with the interface of the immune
system, speciﬁcally generating antibody production early in life. This article focuses on possible origin of
Staphylococci, their role in the nasal microbiome, the host beneﬁt via their presence in the microbiome,
and their role in creation.
Resident nose bacteria are highly diverse, and an understanding of the nasal microbiome is necessary to
gain insight into microbial involvement in human health and infectious disease. The normal nasal
microbiota provides clues to the pre-Fall function of bacteria. It is “normal” and critical for our body’s
health to be symbiotically inhabited by microbes, such as beneﬁcial bacteria. God’s very good creation
likely included microbes in the nose and throughout the body, and these can provide clues for human
health in the future.
Keywords: Staphylococcus, microbiota, nasal microbiome, respiratory system, immune system, biomatrix, organosubstrate, interwoven complexity,
fearfully and wonderfully made, body by design, genesis of germs
Introduction
In Genesis 2:7, we read that God formed man out of dust from the ground and breathed into his nostrils the breath of life. Then, man came
alive—a living soul! Although God mentions the human nose in Genesis 2:7 and a few other places in the Bible, very few creation articles
cover it. Brian Thomas (2008) and my book, Body by Design (Gillen 2009), declare that the intricate and complex nose is wondrously
designed. I assert that like other parts of the body, it too is wonderfully complex, has intelligent design, has an interwoven design, and is
crafted skillfully.
Enter Staph
Within a week of creation, there is a high likelihood that some of our ﬁrst breaths inhaled Staphylococci in addition to oxygen in the air. It
may have not been our literal ﬁrst breath, but research indicates that most infants carry Staphylococci within a week of birth. I have seen
evidence of this in my own studies at Liberty University.
This article focuses on the Staphylococci, the nasal microbiome, its beneﬁts, and role in creation. According to Elek (1959), there is general
agreement that the main reservoir of S. aureus is the human nose. Skin surfaces harboring S. aureus (Fig. 1) become colonized from the nose,
and bacteria found in wound infections come either directly or indirectly from the nose.
Staphylococci and micrococci of some kind are normal constituents of the nose. Studies since 1938 consistently show 32–34% of adults
carry S. aureus. These results coincide with those found in our studies at Liberty University over four years. Some studies estimate that 85%
of humans will be carriers at some point in their adult lives.
Image by BruceBlaus, via Wikimedia Commons.
Figure 1. Staphylococcus aureus with golden pigment, staphyloxanthin.
Image by Microrao, via Wikimedia Commons.
Figure 2. Simple squamous epithelial cells line the anterior nares and
those ﬁrst colonized by staphylococci. Image by Kamilx3, via Wikimedia
Commons.
Bacteria are in the air—and probably have been since creation. For many,
during our ﬁrst breath of life, we inhaled S. aureus. According to Elek (1959),
early studies of infants in England demonstrated that 96–100% were
colonized by S. aureus by day 14. Some studies showed that by day three of
life, 50% of infants were colonized. Phage typing showed that the strains in
the infant's nose were seldom the same as those in the mother's nose. On
the other hand, the Staphylococci found in the air and dust of the hospital
corresponded with the strains discovered in the noses of babies and nursing
staff (Elek 1959).
The actual ﬁrst site of colonization is the squamous epithelium (Fig. 2) of the
vestibule and multiplication of the organism occurs without invasion of
tissue. Hence, I conclude that these Staphylococci were not likely
pathogenic by original design. After primary colonization occurs, some of
the Staphylococci move posteriorly in the nose and stimulate the ciliated,
pseudostratiﬁed epithelium of the nasopharnyx (Fig. 3); this will stimulate
the mucociliary mechanism. This type of symbiotic existence without
invasion is very normal in infants, and the almost-universal carrier state as
an infant appears to build the rest of the normal microbiota and immune
system associated with the nasal passages.
Image by Cmdrjameson, via Wikimedia Commons.
Figure 3. Ciliated, Pseudo-stratiﬁed, epithelial cells line the nasopharnyx and those last to be colonized by staphylococci.
Most species of Staphylococci (34 of 40) are generally nonpathogenic today. Even S. aureus has some strains that are non-pathogenic. Yes, I
am very aware of pathogenic S. aureus strains and MRSA, as my previously published articles have shown (Gillen 2009b; Gillen, Daycock,
and Seraﬁn 2014). However, the emphasis of this article is to explain some of the “very good” design and purpose of Staphylococci and other
good, beneﬁcial bacteria of the nose.
Nose Anatomy and Physiology
The nose is one of the few openings through which bacteria have direct access to the body interior (Fig. 4). The nasal passage is important
for ﬁltering the air we inhale, as well as for impeding foreign particles and microorganisms from entering the body. The nose and nasal
passages are shielded from direct sunlight, and are warm, well-oxygenated, and moist; this creates an optimum environment for some
bacteria, both good and bad. To understand the physiology of the nose, its functions must be understood. The nose serves as the only means
of bringing warm, humidiﬁed air into the lungs. It is the primary organ for ﬁltering out particles in inhaled air, and it also serves to provide
ﬁrst-line immunologic defense by bringing this inspired air in contact with mucous-coated membranes that contain immunoglobulin A (IgA).
Inspired air with bacteria is brought high into the nasal cavity to come in contact with the microbiome, thereby providing the stimuli for the
production of antibodies and other enzymes, which is intimately associated with lymphatic development. Awareness of the interrelationship
between the upper airways and nasal microbiome has increased. The microbiome, respiratory tract, and immune system are considered to
be an integrated system, each system affecting the others. Hence, changes in the physiology of the nose and microbiota can, and will, affect
the lower airways and vice versa (Marieb & Hoehn 2015). Lining the mucosa with microbes may be part of the embroidery made by the
Master Craftsman at creation (Genesis 2:17).
The nasal cavity (Fig. 5) just above the nostrils is called the nasal vestibule and is lined with glands and numerous hairs. These hairs, or
vibrissae (from vibro = to quiver), ﬁlter coarse particles from the inspired air. Staph colonizes the simple squamous epithelium of the anterior
nare. The rest of the nasal cavity is lined with respiratory mucosa and contains pseudostratiﬁed ciliated columnar epithelium and goblet
cells, which secrete a watery ﬂuid containing enzymes. The glands daily secrete a quart of a mucous containing lysozyme, which is
antibacterial, so staph rarely colonize these posterior areas of the nose. The sticky mucous traps inhaled dust, bacteria, and debris. The
lysozyme attacks bacteria chemically. The epithelial respiratory mucosa also secretes defensins, natural antibiotics that get rid of invading
microbes, although these defensive substances usually do not kill staphylococci. The nasal passageway walls are layered with respiratory
Thank you for making me so wonderfully complex! Your
workmanship is marvelous—how well I know it. You watched me as I
was being formed in utter seclusion, as I was woven together in the
dark of the womb. (Psalm 139:14–15 NLT)
Figure 4. Respiratory Model showing the anatomy of the inner nose.
Image by author.
mucous membranes. The mucous lubricating them is secreted by goblet
cells. These membranes have many cilia, which move mucus in waves toward
the throat area. Bacteria, along with dust and other particles inhaled from
the outside environment, are snared by the nasal mucus, carried back out to
the pharynx, and dripped into the gastric juices to destroy any possible
pathogens. Additionally, the high content of mucous acts to humidify air
(Marieb & Hoehn 2015).
Figure 5. Anatomy of the Nose depicting the inner nasal passages and vestibule where nose
hairs are ﬁrst vibrated by dust and bacteria. Image by Pngbot, via Wikimedia Commons.
Wilson (2004) reported that hairs in the nostrils remove large particles present in inhaled air, while smaller particles and suspended bacteria
become trapped in the mucous covering the nasal mucosa. In the posterior two thirds of the nasal mucosa, the mucociliary escalator propels
the mucous-entrapped particles into the pharynx, and the whole nasal mucosa is replaced within 20 minutes. A wide range of antimicrobial
agents has been detected in this ﬂuid. Lysozyme is one of the major antimicrobial chemicals. About 75% of plasma cells of nasal mucosa are
IgA producing, and 25% produce IgG. They block microbial adhesion for most bacteria. Many of the normal nasal microbiota are resistant to
this antibody clearance and stay adhered to cells. The research suggests that in early life of an infant, these antibodies are not yet present in
numbers. Hence why S. aureus easily adheres in early life, causing the stimulation of IgA and IgG production, and the maturation of the
immune system. The role of the normal microbiota is to stimulate and mature both the second and third levels of defense in immunity
(Bauman 2014). Bomar (2016) reports that this includes stimulation of lymphocytes and neutrophils (Fig. 6). These microbes were meant to
interact with the immune system from the beginning. Many studies show that animals grown in axenic, or gnotobiotic (microbe-free)
environments, have weaker immune systems and abnormal physiological systems.
As an infant becomes a toddler, antibody production increases. After this, only 1/3 of the population will carry S. aureus continuously for
much of life. S. epidermidis (and other coagulase-negative Staph) remain for life in all humans. The 1/3 of the population that carries S.
aureus for life may have an environmental base, not a genetic base. In a new study (Bomar 2016), scientists hypothesize those interactions
between pathogens and other normal microbiota are an important aspect of nasal bacteria colonization. Thus, in addition to deﬁning
bacteria composition, microbiologists use bacterial counts to look for shifts in the bacterial population in the presence or absence
of Streptococcus pneumoniae (pneumococcus) or S. aureus during a state of health versus disease. This knowledge is then examined for
clues as to which bacteria might be interacting with each other. These clues are often in the form of positive or negative correlations of
relative bacterial abundances in relation to a speciﬁc bacterium or disease. Studies by Bomar (2016), a Dartmouth research group, used this
approach with a goal of understanding how benign human nasal bacteria, including Staphylococci, might protect against pneumonia bacteria
—a more serious threat than MRSA most of the time.
We have observed that 100% of our students carry S. epidermidis (or other coagulase-negative bacteria, CoNS) and 33% carry S.
aureus (Table 1). The probable reason why about 1/3 of our students are populated by S. aureus in the nasal passageway is due to the
Figure 6. White blood cells. Normal microbiota commensals stimulate the
immune system. Image by BruceBlaus, via Wikimedia Commons.
negative symbiotic behavior S. epidermidis and other bacteria have with S. aureus. Bacteria compete with one another for space through the
synthesis of bacteriocins, bacteriolytic enzymes, etc. or the competition of speciﬁc attachment to epithelial cells. There are S. aureus strains
that produce bacteriocin against some bacterium species, and some S. epidermidis strains produce bacteriocins against S. aureus (Fig. 7). The
ability to bind to the epithelial cells involves the carbohydrate portion of the human nasal mucin enzyme for support. Competition for space
on the mucosal surface in the nasopharyngeal region exists between bacteria as well. These bacterial species compete for limited space in
order to form stable colonies and propagate.
The Staphylococcus “Kind”—Family Staphylococcaceae
The Staphylococcus “kind” is a rather hardy Gram-positive bacteria type and is especially resistant to drying (Fig. 6). The ﬁrst Staphylococci
probably carried a diversity of genes and were able to adapt to varying microhabitats. Over time, minor changes took place (that is,
variation): some of the Staphylococcus kind became S. epidermidis to occupy most of the body’s surface and nose. S. epidermidis seems quite
adapted to living in both the nose and on the salty areas of the body’s surface, including speciﬁc pH environments. On the other hand, S.
aureus tends to occupy moist places of the body like the anterior nares of the nose and mucous membranes and tolerates a lower pH than S.
epidermidis. Perhaps the original Staphylococcus kind diversiﬁed into several varieties according to microhabitat: some to live in low pH and
others for the high pH of the nose, speciﬁcally the anterior nare, nasal cavity, mucosal surface, and the nasopharnyx. S. aureus and S.
epidermidis are two of 40 identiﬁed Staphylococcus species (Figs. 7–9).
At this time, over 40 species of Staphylococcus have been discovered. Many
of these are found in and on the human body. While Staphylococcus is
resilient and can grow at a variety of temperatures and chemical conditions,
it functions very well under the conditions and temperature of the human
body (Gillen 2009, 2015). S. aureus and S. epidermidis are found on the
outer layers of the skin, in hair follicles, and on the nasal membranes. S.
aureus are abundant in the nose, armpits (axilla), and moist areas of the
body. S. epidermidis are abundant on the surface of dry skin, and sometimes
are called the “skin ﬂake” bacteria. Other types of staphylococci are also
found on the conjunctiva of the eyes, the mucus membranes that line the
upper respiratory tract, and the linings of the gastrointestinal and urogenital
tracts. These types of Staphylococci are normally beneﬁcial to humans, but
can, at times, be harmful (Gillen 2014).
Some positive values of Staphylococcus include the ability to interact and
engage the immune system and the ability to produce bacteriocins (i.e.,
natural antibiotics) (Tortora, Funke, and Case 2015). Bacteriocins are
chemicals produced by bacteria that kill or stem the growth of a closely
related type of bacteria. The varieties of Staphylococcus that are not
harmful to humans when they exist solely on the skin produce bacteriocins
that inhibit the existence of harmful bacteria on our skin. This symbiotic
Table 1. Sample Class Data from Fall, 2016 Staph Carriage Rate BIOL 203
Section # Number of Students S. aureus S. epidermidis*
1 25 8 (32%) 25 (100%)
2 21 6 (29%) 21 (100%)
3 24 6 (25%) 24 (100%)
4 24 5 (17%) 24 (100%)
5 23 9 (39%) 23 (100%)
6 17 5 (29%) 17 (100%)
2016 Total 117 39 (33.3%) 117 (100%)
National Average (millions) 33% 100%
Adaptation to the nose. 1/3 since 2013-14 (Gillen, Daycock, Saraﬁn, 2014)
*—All Coagulase-Negative staphylococci (CoNS) and  M. luteus
Figure 7. Staphylococcus epidermidis and S. aureus on Mannitol Salt
Agar. S. epidermidis are white colonies on red background and S.
aureus are gold colonies on yellow background. Image by author.
Figure 8. Staphylococcus aureus are Gram-positive cocci with a grape-like
cluster formation. Image by Raeky, via Wikimedia Commons.
Figure 9. Staphylococci grow as white colonies on Blood Agar (5% sheep’s
blood on TSA). Image by author.
Figure 10. Streptococcus pneumoniae, the most common cause of
pneumonia. Image by Splintercellguy, via Wikimedia Commons.
system clearly shows the hand of our loving Creator in preparing us to live in
a fallen, cursed world. The Designer intelligently chose to make bacteria
that keep us safe from other harmful types, and He designed it to ﬂourish at
body conditions.
From First Breath
The ﬁrst breath in the life of Adam may not have had staph in it. But, it is
very reasonable that as Adam breathed air over time, bacteria colonized his
nose. Almost certainly, over time, Adam's descendants would breathe air
that was naturally inhabited by bacteria. This microbiota is normal and
natural and probably essential for the stimulation of the immune system.
Most staph are inhaled from the air in our early life. The air contains dust,
which is largely made of dead epithelial, skin cells, dust mites, and bacteria.
Humans shed 10 billion cells per day, which is about 250 grams (1/2 pound)
per year. Household dust, nurseries, and hospitals are where infants reside
and pick up these bacteria early in life (Fig. 11).
Staphylococci (Fig. 8) interact to stimulate the immune system and play a
role with the interface of the immune system, speciﬁcally generating
antibody production early in life. The simple presence of staph bacteria after
birth can change the environment in the nasal passages, if it is identiﬁed by
the host's immune system.
Another key, beneﬁcial, pediatric nasal bacteria genus
is Corynebacterium. Corynebacterium accolens, a benign member of human
nasal and skin microbiota, inhibits pneumococcal growth on medium
supplemented with triolein. Triolein is a representative human skin
triacylglycerol, similar to the triacylglycerols found on skin lining the
nostrils. Like Staphylococcus, they inhibit the growth of
pathogenic Streptococcus pneumoniae (Fig. 10), the most common cause of
pneumonia (Bomar 2016).
Pediatric Microbiome
Newborns (Fig. 11) acquire microbes from their environment, parents, siblings, and caregivers. Staph would be among the ﬁrst, along with
microbes acquired in the birth canal, breast milk, and food. The vast majority of environmental microbes a child is exposed to will not be
acquired, because they cannot colonize the body. Either they don't have the right receptors or they can't compete with normal microbiota
already present. “An important concept to remember is that of ‘selection.’ As the human microbiome becomes established, there is selection
going on in multiple directions; newly encountered microbes seek an appropriate environment, which includes both the conditions at the
human body site, and the microbes that are already there. At the same time, the human is selecting for microbes that provide needed
services and do not cause harm. Microbes sense and interact with speciﬁc markers that are secreted by cells, or found on their surfaces, and
use these cues to ‘decide’ where to grow” (Reid and Greene 2013). In any event, the set of microbes that ends up constituting a mature
microbiome is far from random; it appears to be by design. During infancy (ﬁrst two years of life), there is a process of adaptation between
the baby and the microbes it encounters.
Figure 11. Infants in nursery. Newborns acquire microbes from their nursery environment, parents, siblings, and caregivers. Image by US National Archives bot, via Wikimedia
Commons.
Research on the microbiome (Fig. 12) is fairly recent and beginning to deﬁne what constitutes a normal microbiome, how it changes over
time, and how the composition and activity of the microbiome affects health and disease. The human microbiome has a profound and
multifaceted effect on the body. Some may even call it “a newly recognized organ,” with a great range of metabolic activities (Reid and
Greene 2013). There are normal microbiota present within both healthy and diseased individuals. Bacteria present within body systems
serve to beneﬁt the healthy host by providing functions that the body would not otherwise be capable of completing, or by occupying niches
that would otherwise be occupied by pathogenic organisms. In addition to beneﬁting the healthy human body, the occupation of the human
host serves to beneﬁt the organisms by providing necessary resources and habitats to ensure that they survive and reproduce. Together, the
normal biota and the human host interact with one another in a complex symbiosis that beneﬁts both species (Fig. 12). This symbiosis,
Figure 12. Normal microbiota grow on the mucous layer of the inner nose,
forming a wondrous weaving of bacteria with the nose. Image by author.
usually classiﬁed as mutualism or commensalism, is a key characteristic of the human species that has likely been present since Creation
(Gillen 2007).
Summary and Conclusions
Besides adding distinction to the human face, the nose is an amazingly
complex masterpiece. The insides of our noses are not just straight hollow
tubes, but are shaped speciﬁcally to regulate airﬂow and allow interaction
with microbes. The stimulation of the immune response by the nasal
microbiome is not a chance event and is a clear evidence of an intricate and
creative design when systems of two independent entities work together in
a seamless operation. A reasonable conclusion is that they were, and are,
designed to work together. These two functions of our immune system—
internal maintenance and regulation of our microbiome—involve more than
just pathogen destruction but can operate for purposes other than
infectious disease protection. Our noses regulate airﬂow direction,
humidiﬁcation, and immune functions by partnering with microbes and the
lymphatic system. Only a wondrous designer could generate such complex
features (Thomas, 2008). It appears that we are interdependent with
microbial life for normal function and interwoven with a complex design
even from our early days of life. The partnership between man and microbes
is just beginning to be explored, but it is important to recognize that this
association between Staphylococci and the nose is not random but one of
intimate association made by the Triune, Creator God.
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